KRONOS AIR DISINFECTION TECHNOLOGY MANUFACTURER RECEIVES FDA 510(K) CLASS II MEDICAL DEVICE CLEARANCE FOR THE DESTRUCTION OF VIRUSES, BACTERIA, AND ALLERGENS. - Seite 2

“There are only a few air purifier manufacturers on the market today that has received 501(k) clearance, and this marks a significant milestone for our company and our shareholders. This certification validates the performance of the Kronos Model 5 air disinfection technology capabilities, as we are getting ready to manufacture our innovative products domestically at our new manufacturing facility and move to dominate the air purification industry.”- commented Joseph Florence, COO of Kronos.

The Model 5, which is the most popular model, has been rigorously tested in several credible international testing labs. Kronos developed technology is an active filtration technology. Unlike other solutions- It generates a high voltage electric field to electrify and destroy harmful particles and collects them on the easy-to-wash uniquely designed collecting plates. Its 3 layers of washable filter technology equate to zero dollars in maintenance costs while eliminating up to 99.9% of Harmful Particles, 99.9% of PM 2.5, and 99% of Chemical Toxins in the air it cleans.

 Traditional HEPA filter-based air filtration systems only capture larger particles such as dust or pet hair and require frequent filter changes to maintain effectiveness, drastically increasing system maintenance costs.  Our technology has the ability to remove contaminants and allergens down to 14.6 nanometers (.0146 microns) which is 20 times smaller than HEPA filters – a definite market advantage.

As reported recently by CNN: Omicron offshoot XBB.1.5 could drive a new Covid-19 surge in the US. The CDC estimates that XBB.1.5 has more than doubled its share of the Covid-19 pie each week for the last four, rising from about 4% to 41% of new infections over December. In the Northeast, the CDC estimates XBB.1.5 is causing 75% of new cases. Americans have been slow to get the new boosters, however. According to CDC data, only 15% of Americans who are eligible have had an updated booster. Among seniors – those age 65 and older – only about 1 in 3 have had an updated shot.

Experts also note that although antibody treatments won’t work against this sublineage, other antivirals, such as Paxlovid and Remdesivir, should still be effective.

Rapid tests continue to work, as do masks, and ventilation and filtration of indoor air, so even as the virus continues to evolve, there are still good ways to protect yourself from getting Covid-19.